Erika Rijavec

3.1k total citations
93 papers, 1.7k citations indexed

About

Erika Rijavec is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Erika Rijavec has authored 93 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 56 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Erika Rijavec's work include Lung Cancer Treatments and Mutations (46 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Lung Cancer Research Studies (18 papers). Erika Rijavec is often cited by papers focused on Lung Cancer Treatments and Mutations (46 papers), Cancer Immunotherapy and Biomarkers (31 papers) and Lung Cancer Research Studies (18 papers). Erika Rijavec collaborates with scholars based in Italy, United States and United Kingdom. Erika Rijavec's co-authors include Francesco Grossi, Carlo Genova, Alice Indini, Simona Coco, Maria Giovanna Dal Bello, Federica Biello, Angela Alama, Giovanni Rossi, Giulia Barletta and Michele Ghidini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Erika Rijavec

92 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erika Rijavec Italy	24	1.1k	707	489	420	253	93	1.7k
Débora De Melo Gagliato Brazil	14	953 0.9×	528 0.7×	426 0.9×	501 1.2×	281 1.1×	36	1.5k
Pascale Tomasini France	22	1.1k 1.1×	1.1k 1.6×	465 1.0×	425 1.0×	143 0.6×	109	1.8k
Nicola Battelli Italy	23	1.0k 0.9×	814 1.2×	512 1.0×	553 1.3×	274 1.1×	91	1.9k
Denis L. Jardim Brazil	21	1.1k 1.0×	671 0.9×	625 1.3×	619 1.5×	310 1.2×	63	2.0k
Penelope A. Bradbury Canada	29	1.1k 1.0×	1.1k 1.6×	604 1.2×	419 1.0×	150 0.6×	112	2.0k
Rohan Garje United States	17	1.1k 1.0×	556 0.8×	429 0.9×	249 0.6×	422 1.7×	79	1.8k
Alex Friedlaender Switzerland	28	1.5k 1.4×	1.1k 1.6×	711 1.5×	437 1.0×	263 1.0×	86	2.3k
Benjamin Levy United States	23	966 0.9×	1.1k 1.6×	526 1.1×	503 1.2×	136 0.5×	97	1.9k
Antonio Galvano Italy	24	996 0.9×	800 1.1×	475 1.0×	540 1.3×	122 0.5×	96	1.8k
Jessica Menis Italy	21	1.2k 1.1×	1.1k 1.6×	381 0.8×	363 0.9×	120 0.5×	76	1.9k

Countries citing papers authored by Erika Rijavec

Since Specialization

Citations

This map shows the geographic impact of Erika Rijavec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Rijavec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Rijavec more than expected).

Fields of papers citing papers by Erika Rijavec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Rijavec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Rijavec. The network helps show where Erika Rijavec may publish in the future.

Co-authorship network of co-authors of Erika Rijavec

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Rijavec. A scholar is included among the top collaborators of Erika Rijavec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Rijavec. Erika Rijavec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bauckneht, Matteo, Carlo Genova, Giovanni Rossi, et al.. (2021). The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. Cancers. 13(13). 3117–3117. 20 indexed citations

Indini, Alice, Erika Rijavec, & Francesco Grossi. (2021). Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors. International Journal of Molecular Sciences. 22(9). 4774–4774. 84 indexed citations

Tomasello, Gianluca, Michele Ghidini, Antonio Ghidini, et al.. (2021). Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2–3 studies. Radiotherapy and Oncology. 164. 13–19. 8 indexed citations

Ghidini, Michele, Alice Indini, Erika Rijavec, et al.. (2021). The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score. Viruses. 13(3). 508–508. 1 indexed citations

Genova, Carlo, Giovanni Rossi, Marco Tagliamento, et al.. (2020). Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives. Expert Review of Respiratory Medicine. 14(4). 367–383. 21 indexed citations

Bonaventura, Aldo, Francesco Grossi, Federico Carbone, et al.. (2020). Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. Clinical & Translational Oncology. 22(9). 1603–1610. 4 indexed citations

Indini, Alice, Fausto Petrelli, Gianluca Tomasello, et al.. (2020). Impact of Use of Gastric-Acid Suppressants and Oral Anticancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis. Preprints.org. 4 indexed citations

Coco, Simona, Simona Boccardo, Marco Mora, et al.. (2020). Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer. Clinical Breast Cancer. 21(3). 218–230.e6. 2 indexed citations

Alama, Angela, Simona Coco, Carlo Genova, et al.. (2019). Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine. 8(7). 1011–1011. 45 indexed citations

10.

Coco, Simona, Silvia Bonfiglio, Davide Cittaro, et al.. (2019). Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers. 11(4). 441–441. 3 indexed citations

11.

Tagliamento, Marco, Francesco Grossi, Sabrina Paolino, et al.. (2019). Nivolumab Treatment in Advanced Lung Cancer Patient With Chronic Active Hepatitis C and Systemic Lupus Erythematosus. Immunotherapy. 11(10). 873–879. 11 indexed citations

12.

Bonaventura, Aldo, Francesco Grossi, Federico Carbone, et al.. (2019). Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. Cancer Immunology Immunotherapy. 68(8). 1351–1358. 28 indexed citations

13.

Tagliamento, Marco, Carlo Genova, Giovanni Rossi, et al.. (2019). Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds. Expert Opinion on Investigational Drugs. 28(6). 513–523. 22 indexed citations

14.

Rijavec, Erika, Simona Coco, Carlo Genova, et al.. (2019). Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges. Cancers. 12(1). 17–17. 93 indexed citations

15.

Genova, Carlo, Simona Boccardo, Marco Mora, et al.. (2019). Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Journal of Clinical Medicine. 8(10). 1566–1566. 23 indexed citations

16.

Tagliamento, Marco, Carlo Genova, Erika Rijavec, et al.. (2018). Afatinib and Erlotinib in the treatment of squamous-cell lung cancer. Expert Opinion on Pharmacotherapy. 19(18). 2055–2062. 27 indexed citations

17.

Rossi, Giovanni, Angela Alama, Carlo Genova, et al.. (2018). The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy. 19(17). 1969–1976. 17 indexed citations

18.

Vanni, Irene, Simona Coco, Anna Truini, et al.. (2015). Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform. International Journal of Molecular Sciences. 16(12). 28765–28782. 33 indexed citations

19.

Coco, Simona, Anna Truini, Angela Alama, et al.. (2014). Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Targeted Oncology. 10(3). 393–404. 35 indexed citations

20.

Genova, Carlo, Erika Rijavec, Giulia Barletta, et al.. (2014). Afatinib for the treatment of advanced non-small-cell lung cancer. Expert Opinion on Pharmacotherapy. 15(6). 889–903. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact